(Q40028472)

16 September 2017

title

Androgen receptor regulates CD168 expression and signaling in prostate cancer (English)

1 reference

16 September 2017

Shi-Lung Lin

1

1 reference

16 September 2017

Donald Chang

series ordinal

2

1 reference

16 September 2017

Angela Chiang

series ordinal

3

1 reference

16 September 2017

Shao-Yao Ying

series ordinal

4

1 reference

16 September 2017

language of work or name

English

0 references

publication date

3 January 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

29

1 reference

16 September 2017

issue

2

1 reference

16 September 2017

page(s)

282-290

1 reference

Signal transduction targets in androgen-independent prostate cancer

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM259

Tensional homeostasis and the malignant phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM259

Hyaluronan stimulates transformation of androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM259

Gene expression in precursor cells of prostate cancer associated with activin by combination of subtractive hybridization and microarray technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM259

Hyaluronan and cell locomotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM259

Hyaluronan: a critical component of epithelial-mesenchymal and epithelial-carcinoma transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM259

The origin of hyaluronectin in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM259

An essential part for Rho-associated kinase in the transcellular invasion of tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM259

Rho kinase and matrix metalloproteinase inhibitors cooperate to inhibit angiogenesis and growth of human prostate cancer xenotransplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM259

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM259

eIF-4E expression and its role in malignancies and metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM259

Strong Stromal Hyaluronan Expression Is Associated with PSA Recurrence in Local Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM259

Heterogeneity in primary and metastatic prostate cancer as defined by cell surface CD profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM259

CD44 Expression in Benign and Neoplastic Human Prostates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM259

RHAMM, a receptor for hyaluronan-mediated motility, on normal human lymphocytes, thymocytes and malignant B cells: a mediator in B cell malignancy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM259

RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM259

Problems with RHAMM: a new link between surface adhesion and oncogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM259

Lost in translation: dysregulation of cap-dependent translation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM259

Inhibition of the Akt, cyclooxygenase-2, and matrix metalloproteinase-9 pathways in combination with androgen deprivation therapy: potential therapeutic approaches for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM259

Androgen receptor signaling in androgen-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM259

PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM259

Transcriptional regulation of androgen receptor gene expression in Sertoli cells and other cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM259

Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM259

Androgen-Independent Prostate Cancer Is a Heterogeneous Group of Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM259

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGM259

1 reference

16 September 2017

1 reference